Accéder au contenu principal

Breaking News: The drugmaker Moderna said its Covid-19 vaccine was powerfully effective in 12- to 17-year-olds. It plans to apply for F.D.A. authorization.

 
View in browser | nytimes.com
The New York Times
 

BREAKING NEWS

The drugmaker Moderna said its Covid-19 vaccine was powerfully effective in 12- to 17-year-olds. It plans to apply for F.D.A. authorization.

Tuesday, May 25, 2021 8:03 AM EST

If approved, Moderna's shot would become the second Covid-19 vaccine available to U.S. adolescents. Federal regulators authorized the Pfizer-BioNTech vaccine this month for 12- to 15-year-olds.

The Pfizer shot was initially authorized for use in people 16 and older, while Moderna's has been available for those 18 and up.

Read the latest

 
You received this email because you signed up for NYTimes.com's Breaking News Alerts. To stop receiving these emails, unsubscribe or manage your email preferences.
Subscribe to the Times Get the NYT app
The New York Times Company, 620 Eighth Avenue, New York, NY 10018
 

Commentaires

Posts les plus consultés de ce blog

Chris Ramsey can take the heat, but what would relegation for QPR mean for black managers in the Premier League?

How a team of innovators overcame the odds to create water from thin air

Britain's health service uses long Twitter thread to explain why it needs more black people to donate blood